Dirk Bornemeier

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Throughout the drug discovery process, discovery teams are compelled to use statistics for making decisions using data from a variety of inputs. For instance, teams are asked to prioritize compounds for subsequent stages of the drug discovery process, given results from multiple screens. To assist in the prioritization process, we propose a desirability(More)
  • 1